Western blotting performed following membrane raft isolation revealed reduced expression of flotillin-2 in the membrane raft fractions of the two treated breast cancer cells, attesting that 4-cholesten-3-one could disrupt the integrity of membrane rafts. This evidence concerns the gene FLOT2 and breast carcinoma.